TAKE Solutions acquires Ecron Acunova Usha Sharma Nov 18, 2015 Targets the largely untapped biosimilars, regenerative medicine and diagnostic imaging agents space by increasing its IP assets
Biocon-Mylan programmes make clinical progress Sanjiv Das May 7, 2015 PEG-G-CSF and Adalimumab enter phase II while patient recruitment for one insulin Glargine phase II study is complete Biocon has…
